Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study.

By Víctor S. Peña, M. Miravitlles, R. Gabriel, C. Jiménez-Ruiz, C. Villasante, Juan F. Masa, J. Viejo, L. Fernández-Fau. Chest, 2000

746 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “Недостаточное распознавание и гиподиагностика ХОБЛ по прежнему влияют на точность данных о смерт ности [14, 15].”
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, background): “Underrecognition and underdiagnosis of COPD still affect the accuracy of mortality data (8, 9) with COPD often listed as a contributory cause of death or omitted from the death certificate entirely (10).”
Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. (2007, background): “In contrast to other sources of data (22, 24), this study revealed higher COPD prevalence in ex-smokers than in current smokers and a higher relative OR for COPD in ex-smokers after adjusting for index of smoking and other variables.”
Global burden of COPD: systematic review and meta-analysis (2006, methodology): “Diagnostic criteria for spirometry-based prevalence estimates from 26 studies are presented in table 3. Of the 26 spirometric COPD estimates, five studies excluded asthma [27, 48, 54 , 57, 67].”